I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Bodrogi, I.
43
results:
Search for persons
X
Format
Online (43)
Mediatypes
Articles (Online) (28)
OpenAccess-fulltext (15)
Languages
english (41)
Sorted by: Relevance
Sorted by: Year
?
1
SATRAPLATIN (S) INCREASES PROGRESSION-FREE SURVIVAL (PFS) A..:
Sternberg, N.
;
Sartor, O.A.
;
Petrylak, D.P.
...
European Urology Supplements. 7 (2008) 3 - p. 230 , 2008
Link:
https://doi.org/10.1016/..
?
2
A RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE II STUDY..:
Horti, J.
;
Widmark, A.
;
Stenzl, A.
...
European Urology Supplements. 7 (2008) 3 - p. 231 , 2008
Link:
https://doi.org/10.1016/..
?
3
Phase I study of TZT-1027, a novel synthetic dolastatin 10 ..:
Horti, J.
;
Juhasz, E.
;
Monostori, Z.
...
Cancer Chemotherapy and Pharmacology. 62 (2008) 1 - p. 173-180 , 2008
Link:
https://doi.org/10.1007/..
?
4
4010 POSTER Satraplatin increases progression-free survival..:
Sternberg, C.
;
Sartor, O.
;
Petrylak, D.
...
European Journal of Cancer Supplements. 5 (2007) 4 - p. 282 , 2007
Link:
https://doi.org/10.1016/..
?
5
4502 ORAL Phase 2 study of irinotecan and cisplatin in epid..:
Theodore, C.
;
Skoneczna, I.
;
Bodrogi, I.
...
European Journal of Cancer Supplements. 5 (2007) 4 - p. 299 , 2007
Link:
https://doi.org/10.1016/..
?
6
HER-2/neu as a Predictive Marker in a Population of Advance..:
Di Leo, A.
;
Chan, S.
;
Paesmans, M.
...
Breast Cancer Research and Treatment. 86 (2004) 3 - p. 197-206 , 2004
Link:
https://doi.org/10.1023/..
?
7
883 Expression and clinical relevance of the lung resistanc..:
Mandoky, L.
;
Geczi, L.
;
Doleschall, Z.
...
European Journal of Cancer Supplements. 1 (2003) 5 - p. S266 , 2003
Link:
https://doi.org/10.1016/..
?
8
992 Human phase II/A study of a novel somatostatin analogue..:
Gyergyay, F.
;
Gödény, M.
;
Szüts, T.
...
European Journal of Cancer Supplements. 1 (2003) 5 - p. S297 , 2003
Link:
https://doi.org/10.1016/..
?
9
Clinical characteristics, treatment and outcome of patients..:
Geczi, L.
;
Gomez, F.
;
Bak, M.
.
European Journal of Cancer. 37 (2001) - p. S225 , 2001
Link:
https://doi.org/10.1016/..
?
10
PET reveals increased metabolic activity of the spinal cord..:
Esik, O.
;
Bodrogi, I.
;
Csere, T.
...
International Journal of Radiation Oncology*Biology*Physics. 51 (2001) 3 - p. 236-237 , 2001
Link:
https://doi.org/10.1016/..
?
11
Long term effect of oral testosterone substitution therapy ..:
Horti, J.
;
Petranyi, A.
;
Forgacs, S.
.
European Journal of Cancer. 37 (2001) - p. S224-S225 , 2001
Link:
https://doi.org/10.1016/..
?
12
Environmental or hereditary risk of cancer in testicular tu..:
Gundy, S.
;
Babosa, M.
;
Baki, M.
.
European Journal of Cancer. 37 (2001) - p. S223 , 2001
Link:
https://doi.org/10.1016/..
?
13
A randomized phase II trial assessing irinotecan (IRI) and ..:
Pozzo, C.
;
Pyrhönen, S.
;
Bodrogi, I.
...
European Journal of Cancer. 35 (1999) - p. S70 , 1999
Link:
https://doi.org/10.1016/..
?
14
Testicular self-examination (TSE) and testicular ultrasound..:
Géczi, L.
;
Bodrogi, I.
European Journal of Cancer. 35 (1999) - p. S347 , 1999
Link:
https://doi.org/10.1016/..
?
15
Significance of examination of prostate-specific antigen an..:
Romics, I.
;
Frang, D.
;
Bodrogi, I.
International Urology and Nephrology. 29 (1997) 4 - p. 449-455 , 1997
Link:
https://doi.org/10.1007/..
1-15